$Virios Therapeutics(VIRI.US)$Virios Therapeutics - Discussions Are Ongoing as We Seek a Partner to Advance Imc-1 Into Phase 3 Development for Treatment of Fm
$Virios Therapeutics(VIRI.US)$Virios Therapeutics Announces Publication Of International Patent For IMC-2 Covering Antiviral Treatment Of Long-COVID Benzinga· 1 min ago
$Virios Therapeutics(VIRI.US)$Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent.
$Virios Therapeutics(VIRI.US)$Virios Therapeutics: Discussions Ongoing With Potential Partners to Fund Advancement of IMC-1 Into Phase 3 Development for FM >VIRI Dow Jones· just